BioCryst Pharmaceuticals
BCRX
#4769
Rank
NZ$3.82 B
Marketcap
NZ$15.05
Share price
-1.78%
Change (1 day)
1.92%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -NZ$0.8 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.88 Billion. In 2025 the company made an earning of NZ$0.45 Billion, an increase over its 2024 earnings that were of -NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.8 Billion-273.74%
2025 NZ$0.45 B-407.51%
2024 -NZ$0.15 Billion-61.56%
2023 -NZ$0.39 Billion-7.43%
2022 -NZ$0.42 Billion34.42%
2021 -NZ$0.32 Billion-0.55%
2020 -NZ$0.32 Billion67.88%
2019 -NZ$0.19 Billion7.55%
2018 -NZ$0.18 Billion53.92%
2017 -NZ$0.12 Billion19.29%
2016 -NZ$94.07 Million28.19%
2015 -NZ$73.39 Million-4.8%
2014 -NZ$77.09 Million50.09%
2013 -NZ$51.36 Million-23.29%
2012 -NZ$66.96 Million-26.19%
2011 -NZ$90.71 Million54.78%
2010 -NZ$58.61 Million150.1%
2009 -NZ$23.44 Million-49.43%
2008 -NZ$46.34 Million14.07%
2007 -NZ$40.62 Million-49.31%
2006 -NZ$80.14 Million72.87%
2005 -NZ$46.36 Million22.08%
2004 -NZ$37.98 Million75.3%
2003 -NZ$21.67 Million-25.36%
2002 -NZ$29.03 Million225.05%
2001 -NZ$8.93 Million-56.6%
2000 -NZ$20.58 Million50.63%
1999 -NZ$13.66 Million38.05%
1998 -NZ$9.9 Million-52.46%
1997 -NZ$20.82 Million58.44%
1996 -NZ$13.14 Million-14.44%
1995 -NZ$15.36 Million28.57%
1994 -NZ$11.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$18.29 B-2,462.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.07 B-2,304.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$41.73 M-105.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.13 B-117.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.11 Billion-85.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.53 Billion-31.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$13.81 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$37.87 Million-95.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.10 B-113.01%๐Ÿ‡บ๐Ÿ‡ธ USA